Hanas, R. & Ludvigsson, J. (1990). Side Effects and Indwelling Times of Subcutaneous Catheters for
Insulin Injections: a new device for injecting insulin with a minimum of pain in the treatment of
insulin-dependent diabetes mellitius.
Diabetes Research and Clinical Practice, 10, 73-83.

Hanas, R. & Ludvigsson, J. (1994). Metabolic Control Is Not Altered When Using Indwelling
Catheters for Insulin Injections.
Diabetes Care, (17)7, 716-718.

Hanas, R., Adolfsson, P., et al. (2002). Indwelling Catheters Used from the Onset
of Diabetes Decrease Injection Pain and Pre-Injection Anxiety.
The Journal of Pediatrics, (140)3, 315-320.

Streif, W., Goebel, G., Chan, A.K.C. & Massicotte, M.P. (2003). Use of Low Molecular
Mass Heparin (Enoxaparin) in Newborn Infants: a prospective cohort study of 62 patients.
Archives of Diseases in Childhood Fetal Neonatal, 88, F365-F370.

Anderson, D.R., Ginsberg J.S., et al. (1993). The Use of an Indwelling Teflon Catheter
for Subcutaneous Heparin Administration During Pregnancy: a randomized crossover study.
Archives of Internal Medicine, 153, 841-844.

Dyer, S., Collins C., Baghurst P., Saxon B. & Meachan, B. (2004). Insuflon Versus
Subcutaneous Injection for Cytokine Administration in Children and Adolescents:
a randomized crossover study.
Journal of Pediatric Oncology Nursing (21)2, 79-86

De Jong, M.E.A, Carbiére, T. & van den Heuvel-Eibrink, M.M. (2005). The Use of an Insuflon
Device for the Administration of G-CSF in Pediatric Cancer Patients.
Supportive Care in Cancer, (14), 1, 98-100.

Lamacraft, G., Cooper, M. & Cavalletto, B. (1997). Subcutaneous Cannulae for Morphine
Boluses in Children: assessment of a technique.
Journal of Pain and Symptom Management (13)1, 43-49.